Chronic myelogenous leukemia

Susan O'Brien*, Camille N. Abboud, Mojtaba Akhtari, Jessica Altman, Ellin Berman, Daniel J. DeAngelo, Steven Devine, Amir T. Fathi, Jason Gotlib, Madan Jagasia, Joseph O. Moore, Javier Pinilla-Ibarz, Jerald P. Radich, Vishnu V.B. Reddy, Neil P. Shah, Paul J. Shami, B. Douglas Smith, David S. Snyder, Meir Wetzler, Furhan Yunus

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations
Original languageEnglish (US)
Pages (from-to)64-110
Number of pages47
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume10
Issue number1
DOIs
StatePublished - Jan 1 2012

Keywords

  • BCR-ABL
  • Chronic myelogenous leukemia
  • Dasatinib
  • Imatinib
  • NCCN clinical practice guidelines
  • NCCN guidelines
  • Nilotinib
  • Stem cell transplant
  • Tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Oncology

Cite this